AZTherapies, Inc.

Poland’s biopharma sector is best known for its strengths in generics and biosimilars, with companies like Polpharma SA providing central Europe and beyond with a reliable flow of affordable off-pat

The requirement for Biogen, Inc. and Eisai Co., Ltd. to conduct a Phase IV clinical trial as a condition of Aduhelm’s accelerated approval raises the question of whether Alzheimer’s disease patien

Artificial intelligence and machine learning have moved from buzzwords to long-term business strategies in biopharmaceutical drug development with hundreds of millions of dollars invested in individua